Cargando…

TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions

CONTEXT: Tangnaikang (TNK) is a Chinese herbal formulation that has lipid-lowering effects, but its effect on reducing obesity has not been studied. OBJECTIVE: To observe the effect of TNK on obesity and explore its effect on gut microbiota of obese rats. MATERIALS AND METHODS: The SHR/NDmcr-cp rats...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Peng, Wu, Lili, Kudo, Maya, Hayashi, Misa, Qin, Lingling, Gao, Ming, Xu, Anlong, Liu, Tonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578476/
https://www.ncbi.nlm.nih.gov/pubmed/36226871
http://dx.doi.org/10.1080/13880209.2022.2096075
_version_ 1784811971775823872
author Tian, Peng
Wu, Lili
Kudo, Maya
Hayashi, Misa
Qin, Lingling
Gao, Ming
Xu, Anlong
Liu, Tonghua
author_facet Tian, Peng
Wu, Lili
Kudo, Maya
Hayashi, Misa
Qin, Lingling
Gao, Ming
Xu, Anlong
Liu, Tonghua
author_sort Tian, Peng
collection PubMed
description CONTEXT: Tangnaikang (TNK) is a Chinese herbal formulation that has lipid-lowering effects, but its effect on reducing obesity has not been studied. OBJECTIVE: To observe the effect of TNK on obesity and explore its effect on gut microbiota of obese rats. MATERIALS AND METHODS: The SHR/NDmcr-cp rats were divided into three groups: (1) 3.24 g/kg TNK (High TNK), (2) 1.62 g/kg TNK (Low TNK), and (3) an untreated control (CON). Wistar-Kyoto rats were used as normal controls (WKY). After 8 weeks of TNK oral administration, body weight, abdominal circumference, triglycerides (TC) and total cholesterol (CHO) were measured. Gut microbiota diversity was studied by 16S rDNA sequencing, and metagenomes analysis was conducted to determine alteration in functional gene expression. RESULTS: The body weight (496.60 ± 6.0 g vs. 523.40 ± 5.6 g), abdomen circumference (24.00 ± 0.11 cm vs. 24.87 ± 0.25 cm), TC (3.04 ± 0.16 mmol/L vs. 4.97 ± 0.21 mmol/L), CHO (2.42 ± 0.15 mmol/L vs. 2.84 ± 0.09 mmol/L) of rats in the High TNK group were decreased significantly (all p < 0.05). TNK administration regulates intestinal flora, up-regulates Eisenbergiella and down-regulates Clostridium_sensu_stricto_1, which is beneficial to the production of short-chain fatty acids (SCFAs). Metagenomes analysis shows that TNK is closely related to the fatty acid synthesis pathway. DISCUSSION AND CONCLUSIONS: TNK can regulate gut microbiota to reduce obesity, which may be related to fatty acid metabolism. Our research supports the clinical application of TNK preparation and provides a new perspective for the treatment of obesity.
format Online
Article
Text
id pubmed-9578476
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-95784762022-10-19 TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions Tian, Peng Wu, Lili Kudo, Maya Hayashi, Misa Qin, Lingling Gao, Ming Xu, Anlong Liu, Tonghua Pharm Biol Research Article CONTEXT: Tangnaikang (TNK) is a Chinese herbal formulation that has lipid-lowering effects, but its effect on reducing obesity has not been studied. OBJECTIVE: To observe the effect of TNK on obesity and explore its effect on gut microbiota of obese rats. MATERIALS AND METHODS: The SHR/NDmcr-cp rats were divided into three groups: (1) 3.24 g/kg TNK (High TNK), (2) 1.62 g/kg TNK (Low TNK), and (3) an untreated control (CON). Wistar-Kyoto rats were used as normal controls (WKY). After 8 weeks of TNK oral administration, body weight, abdominal circumference, triglycerides (TC) and total cholesterol (CHO) were measured. Gut microbiota diversity was studied by 16S rDNA sequencing, and metagenomes analysis was conducted to determine alteration in functional gene expression. RESULTS: The body weight (496.60 ± 6.0 g vs. 523.40 ± 5.6 g), abdomen circumference (24.00 ± 0.11 cm vs. 24.87 ± 0.25 cm), TC (3.04 ± 0.16 mmol/L vs. 4.97 ± 0.21 mmol/L), CHO (2.42 ± 0.15 mmol/L vs. 2.84 ± 0.09 mmol/L) of rats in the High TNK group were decreased significantly (all p < 0.05). TNK administration regulates intestinal flora, up-regulates Eisenbergiella and down-regulates Clostridium_sensu_stricto_1, which is beneficial to the production of short-chain fatty acids (SCFAs). Metagenomes analysis shows that TNK is closely related to the fatty acid synthesis pathway. DISCUSSION AND CONCLUSIONS: TNK can regulate gut microbiota to reduce obesity, which may be related to fatty acid metabolism. Our research supports the clinical application of TNK preparation and provides a new perspective for the treatment of obesity. Taylor & Francis 2022-10-13 /pmc/articles/PMC9578476/ /pubmed/36226871 http://dx.doi.org/10.1080/13880209.2022.2096075 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tian, Peng
Wu, Lili
Kudo, Maya
Hayashi, Misa
Qin, Lingling
Gao, Ming
Xu, Anlong
Liu, Tonghua
TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions
title TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions
title_full TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions
title_fullStr TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions
title_full_unstemmed TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions
title_short TangNaiKang, herbal formulation, alleviates obesity in diabetic SHR/cp rats through modulation of gut microbiota and related metabolic functions
title_sort tangnaikang, herbal formulation, alleviates obesity in diabetic shr/cp rats through modulation of gut microbiota and related metabolic functions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578476/
https://www.ncbi.nlm.nih.gov/pubmed/36226871
http://dx.doi.org/10.1080/13880209.2022.2096075
work_keys_str_mv AT tianpeng tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions
AT wulili tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions
AT kudomaya tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions
AT hayashimisa tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions
AT qinlingling tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions
AT gaoming tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions
AT xuanlong tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions
AT liutonghua tangnaikangherbalformulationalleviatesobesityindiabeticshrcpratsthroughmodulationofgutmicrobiotaandrelatedmetabolicfunctions